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Abstract
Genetic, dietary and immune factors contribute to the pathogenesis of atherosclerosis in humans and mice. Complement
activation is an integral part of the innate immune defence but also shapes cellular responses and influences directly
triglyceride synthesis. Deficiency of Factor B of the alternative pathway (AP) of complement is beneficial in LDLR2/2 mice
fed a high fat diet. The serum glycoprotein properdin is a key positive regulator of the AP but has not been studied in
experimental atherosclerosis. Atherosclerosis was assessed after feeding low fat (LFD) or high fat (HFD) Western type diets
to newly generated LDLR2/2 ProperdinKO (LDLR2/2PKO) and LDLR2/2PWT mice. Lipids, lymphocytes and monocytes were
similar among genotypes, genders and diets. Complement C3, but not C3adesarg, levels were enhanced in LDLR
2/2PKO mice
regardless of diet type or gender. Non-esterified fatty acids (NEFA) were decreased in male LDLR2/2PKO fed a HFD
compared with controls. All mice showed significant atherosclerotic burden in aortae and at aortic roots but male LDLR2/2
mice fed a LFD were affected to the greatest extent by the absence of properdin. The protective effect of properdin
expression was overwhelmed in both genders of LDLR2/2mice when fed a HFD. We conclude that properdin plays an
unexpectedly beneficial role in the development and progression of early atherosclerotic lesions.
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Introduction
Atherosclerosis is a progressive inflammatory condition resulting
in cellular changes in the arterial intima with fatty deposits, so-
called atheroma. Oxidatively modified low density lipoproteins
(oxLDLs) are involved and are associated with elevated levels of
lipoproteins in blood. High cholesterol and fatty diets are priming
events.
The innate immune system is central to the pathology and plays
a role in initiation and progression of the disease [1]. Complement
(C) and complement activation are key elements of the innate
immune system. There are three pathways by which the C system
can be activated: classical pathway (CP), lectin pathway (LP) and
the alternative pathway (AP) [2] [3]. The enzymatic generation of
C3a from C3 and subsequently C5a from C5 with relevant
receptors (C3aR, C5aR and C5L2) leads to complement-mediated
chemoattraction of inflammatory cells. In atherosclerotic lesions,
the complement anaphylatoxins C3a and C5a bind to receptors
expressed by plaque intima macrophages, T cells, mast cells,
endothelial and medial smooth muscle cells and therefore have a
role in orchestrating the inflammatory component of atheroscle-
rosis. Properdin is the only naturally occurring positive regulator of
complement activation, leading to an amplification of ongoing
complement activation. Macrophages in the atherosclerotic
plaques may present as lipid laden foam cells and can be of M1
or M2 phenotype [4]. Our recent work has shown that properdin-
deficient mice in comparison with their littermate wildtype
controls exhibit an immune response which is compatible with a
bias towards M2 activity [5].
Previous data in mouse models of atherosclerosis (ApoE2/2
and/or LDLR2/2 background) show the involvement of the
following complement components in the pathogenesis; C3, C1q,
CD59, CD55 also known as decay accelerating factor (DAF), and
MBL (reviewed in [6]) with an emerging role for C3adesArg in
particular. C3adesArg, which is generated by carboxypeptidase
mediated removal of the carboxyl-terminal arginine of C3a, is also
known as acylation stimulating protein (ASP) due to its marked
stimulating action on triacylglycerol synthesis in adipocytes.
The intact alternative pathway of complement plays a pro-
atherogenic role in response to a high fat diet in mice [7]. No study
has yet examined the effect of genetic deletion of properdin on
atherosclerosis. Properdin is a non-enzymatic serum glycoprotein
and is the only positive regulator of AP. Typically oligomers of
properdin interact with Factor B bound C3b to stabilize the
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alternative C3 and C5 convertases that then cleave more C3 and
C5.
Here, we examined the effect of genetic deletion of properdin
on murine atherosclerosis in LDLR2/2 mice of both genders by
feeding Western type diets. Our study reveals an unexpected
protective effect of properdin in early atherosclerotic plaque
progression.
Materials and Methods
Mice and Diets
LDLR2/2 mice (Ldlrtm1Her/J) on C57BL/6 background were
available from Jackson Laboratories and crossbred with a
previously generated properdin-deficient (PKO) mouse line [8].
As properdin is on the X-chromosome, the strategy was to mate
female LDLR2/2 with male PKO. From their offspring, LDLRhet
Phet were intercrossed with LDLRhet PWT. Their litter contained
LDLR2/2 Phet and LDLR2/2 PKO, which were intercrossed in a
final step to generate the experimental mice. Subsequently,
breeding pairs were maintained to generate LDLR2/2 PKO
double knockouts along with LDLR2/2 PWT mice. Polymerase
chain reaction was used to confirm genotypes [8] and http://
jaxmice.jax.org/strain/002077.html#genotype. All mice were
used in accordance with UK legislation (1986 Animals (Scientific
Procedures) Act) and were housed in a controlled environment
with a 12 h light/dark cycle at 22uC. All animal experiments were
carried out in strict accordance with the recommendations in the
guide for the Conduct of Animal Research, National Institutes of
Health. The protocols were approved by the Universities of
Sheffield and Leicester Project Review Committees and carried
out under UK Home Office Project Licences (40/3307).
All animals were fed a standard chow until they reached 15
weeks of age. Mice were then fed either a low-fat (LFD, Arieblok
Reference Diet, cat. 4068.02, Woerden, The Netherlands,
consisting of 54.3% (w/v) glucose, 10% (w/v) cornstarch, 5%
(v/v) soya oil, 20% (w/v) casein, total fat content 5.2% by weight
and no added cholesterol) or high-fat diet (HFD, Arieblok Diet W,
cat. 4021.06, consisted of 15% (w/v) cocoa butter, 1% (v/v) corn
oil, 0.25% (w/v) cholesterol, 40.5% (w/v) sucrose, 10% (w/v)
cornstarch, 20% (w/v) casein, free of cholate, total fat content 16%
by weight) respectively as used by others in the complement field
[7]. Body weights were obtained every 4 weeks. After 12 weeks of
feeding a LFD or HFD, respectively, the mice were euthanized by
pharmacological overdose of pentobarbitone at the age of 27
weeks. Cardiac puncture was performed to obtain blood before
hearts and aortae were perfusion-fixed with phosphate buffered
saline (PBS) followed by 10% (w/v) formalin buffered saline.
Blood Pressure Measurements
Mean blood pressure was calculated after measuring systolic
and diastolic blood pressures of mice at least weekly using a
Visitech tail-cuff system (Visitech Systems, NJ, USA). Weekly
measurements over the entire feeding period were averaged for
each individual mouse and group results were calculated as mean
6 SEM.
Atherosclerotic Plaque Assessment
Thoracic aortae were removed and fixed in 4% (w/v)
paraformaldehyde (PFA, BDH) as described previously [9]. The
aorta was segmented at the diaphragm and the ascending aorta.
The extraneous fatty and connective tissue around the aorta were
carefully trimmed off under a dissecting microscope until a clear
and transparent aorta was obtained; this was then transected
longitudinally. Thoracic aortae were returned to 4% (w/v) PFA
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Figure 1. Development of atherosclerotic plaques in LDLR2/2 PWT and LDLR2/2PKO mice fed LFD and HFD. Atherosclerosis-prone
mice (males and females) lacking properdin were fed low fat or high fat diets for 12 weeks. Atherosclerosis burden was assessed in aortae and at
aortic roots. (A) lesion burden in aortae identified by Oil Red O staining (stains lipid) was calculated from light microscopic images using NIS elements
software (Nikon), (8 per group, mean and IQR), *p,0.05, **p,0.01, intergenotype comparisons were by one way ANOVA with post test. (B) Plaque
area within aortic roots measured from histological images (NIS elements), n = 5–8, data are mean and IQR **p,0.01, intergenotype comparisons
were by one way ANOVA with post test. (C) Representative Oil Red O images of whole aortae from each group. (D) Visualisation of plaques at the
Atherosclerosis in LDLR Properdin Deficient Mice
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for 24 h, stained with Oil Red O for 15 min and pinned onto wax.
A macroscopic CCD camera was used to take images, which were
analysed using computer assisted image analysis (NIS-elements/
Lucia G software, Nikon UK). Total aorta and total lesion area
with positive staining (mean lesion area, number of objects) were
quantified for each aorta. Thereafter, area of positive staining for
Oil Red O was calculated as the ratio of mean lesion area and total
aorta area and expressed as percentage of total aortic area.
Immunohistochemistry
Hearts were fixed in 10% (v/v) formalin buffered saline for at
least 24 h, embedded in paraffin wax and cut serially to obtain 5–
8 mm aortic root sections.
Aortic sinus sections were dewaxed in xylene and rehydrated in
an ethanol series. Primary antibodies diluted as appropriate in
PBS were: monoclonal mouse anti-human smooth muscle actin
(SMA, Dako M0851, 1:150, 1 h), purified anti-mouse CD206
(Biolegend 123001, rat IgG2ak, 1:100, 1 h RT), (trypsination for
antigen retrieval: 0.1% Trypsin (DIFCO 215240) in TBS (Sigma
T6664), 10 min, 37uC; 0,5% Triton-X 100) and were followed by
biotinylated goat anti-mouse IgG (H+L) (Vector BA9200, 1:500,
K–1 h) or polyclonal biotinylated rabbit anti-rat Ig (Dako E0468,
1:500, 1 h RT) and ABC-peroxidase solution (Vektor PK6100,
Vectastain Elite ABC Kit; Sigma H1009; 30 min) with 3,39-
diaminobenzidine tetrahydrochloride (DAB, Sigma D4418,
10 min) as substrate. Carazzi’s haematoxylin was used for
counterstaining.
Analysis was performed using a computer assisted imaging
programme (Nikon-Imaging-Software NIS-elements/Lucia G
software, Nikon UK) and data were generated for mean lesion
area and lesion area:cross-sectional area (CSA). Positive staining
was quantified in blind fashion and expressed as percentage of
total aortic area for en face Oil Red O staining and percentage of
aortic CSA for SMA staining. A cell index was generated for MAC
387 and CD206 by counting positive stained cells/total cells in
high power fields.
Haematology
White blood cells (WBC), red blood cells (RBC), platelets (PLT)
and cell composition of neutrophils (NEUT), monocytes (MXD)
and lymphocytes (LYM) were analysed and counted in a 1:10
dilution of whole blood in cellpack solution at 0, 6 and 12 weeks on
diet using Sysmex KX-21N. Haematological parameters were
expressed as concentrations, whereas cell composition was
presented as percentage of cell type in whole blood.
Lipid and Complement Biochemistry
Blood was collected via cardiac puncture into a desuridin-
containing syringe (1:100 in blood) and plasma separated by
centrifugation. Triglyceride and cholesterol levels were measured
at the Department of Clinical Chemistry (Royal Hallamshire
Hospital, Sheffield, UK) using Roche Cobas 8000 modular
analyzer series. C3 levels were measured at the Department of
Infection, Immunity and Inflammation, University of Leicester,
UK using ELISA specific for mouse C3 (Immune Systems Ltd, E-
90C3). Briefly, C3 present in plasma was recognised by a C3-
antibody which was bound to the provided microtitre wells. HRP-
conjugated anti-C3 antibody, which interacts with a chromogenic
substrate, was then added. C3 concentration was interpolated
from a standard curve and corrected for the dilution factor
(1:50,000). The assay may also detect cleaved C3, iC3b.
Non-esterified fatty acids (NEFA) were analysed using mass
spectrometry by the Department of Infection, Immunity and
Biochemistry, Cardiff, UK [10]. C3adesArg was measured in a
previously described sandwich ELISA using a pair of anti-mouse
C3a mAb, one unlabelled as capture (0.2 mg/ml), the other
biotinylated as detection (0.5 ug/ml), and recombinant mouse
C3a (100 ng/ml –0.78 ng/ml) as standards (all from BD
Pharmingen, San Diego, CA). This assay measures both C3a
and C3desArg. Appropriately diluted plasma samples were includ-
ed. The assay was developed with streptavidin-peroxidase (1:5000;
Jackson ImmunoResearch. West Grove, PA).
For NEFA, lipids were extracted and separated by 1-dimen-
sional TLC on 10610 cm silica gel G plates, double developed
using toluene: hexane: formic acid (140:60:1, (v/v)) for the entire
plate followed by hexane: diethyl ether: formic acid (60:40:1, (v/v))
to half height. Plates were sprayed with 0.05% (wt/vol) 8-anilino-
4-naphthosulphonic acid in methanol and viewed under UV light
to reveal lipids. Free fatty acids were scraped from the plate and
identified and quantified by gas chromatography.
Molecular Analyses on Splenocytes
For RTPCR analysis, RNA was extracted from spleens or from
splenic macrophages (adherent cell population after overnight
incubation of splenic single cell suspensions) and RTPCR
performed. Primers used were (annealing temperatures are
indicated); for C3 59-gaatacgtgctgcccagttt-39 and 59-tgagtgaccac-
cagcacttt-39 (55uC); for MCP-1 59-cactcacctgctgctactcattcac-39
and 59-ggattcacagagagcgaaaaatgg-39 (57uC); for sPla2V 59-aa-
gagggttgtaagtccagagg-39 and 59-cagggggcttgctagaactcaa-39 (58uC);
for b-actin 59-gtgggccgctctaggcaccaa-39 and 59-ctctttgatgtcacgcac-
gatttc-39 (55uC). Quantitative PCR for arginase (59-gatgagaaag-
gaaagtggctgt-39 and 59-aggaactggctgaagtggttagt-39, 215 bp, 55uC)
and GAPDH (59-cctggagaaacctgccaagtatg-39 and 59-agagtgg-
gagttgctgttgaagtc-39, 133 bp, 55uC) was performed using SensiMix
SYBR kit (Bioline Reagents Ltd., London), and analysed with
Rotor-Gene 6000 (Corbett Life Science). Relative expressions
were calculated using the DD CT method.
Lipid Storage Assay in Macrophages
Bone marrow derived macrophages were differentiated with
10 ng/ml rmGMCSF (Peprotech) in RPMI 1640 medium
containing 10% (v/v) foetal bovine serum for seven days from
cells isolated from femurs of 10–12 week old mice. They were then
fixed and stained with Oil red O for 15 minutes at room
temperature. Using light microscopy, cells were evaluated blinded
for inclusion of Oil Red O lipid droplets.
Statistics
All data are expressed as mean 6 SEM and significance tested
by two-way ANOVA and non-parametric testing with the Mann–
Whitney U test (GraphPad Prism software version 5.0), with
significance assumed at *p,0.05, **p,0.01, ***p,0.001, ****p,
0.0001.
aortic root in each of the groups, arrowhead indicates a large plaque in male LDLR2/2PKO, arrows indicate typical plaques in the other mouse groups
that were studied.
doi:10.1371/journal.pone.0092404.g001
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Results
Dietary Model of Mild and Advanced Atherosclerosis in
LDLR2/2
Previous in vivo studies on atherosclerosis and the role of
complement have used different diets and genders of mice but
rarely low fat (LFD) and high fat diets (HFD) in one single study.
We fed LFD and HFD to both genders of age matched LDLR2/2
and LDLR2/2 PKO for 12 weeks in the same study. Body weight
was increased after HFD compared to LFD but there was no
difference amongst the sex-matched genotypes (Table 1). HFD led
to significant hypertriglyceridemia and hypercholesterolemia, with
elevated HDL and LDL cholesterol (Table 1). Female LDLR2/2
mice on HFD had the highest cholesterol levels, irrespective of
properdin status. Levels of non-esterified fatty acids (NEFA)
liberated by hydrolysis of triglycerides by hormone sensitive lipase
were significantly decreased in male LDLR2/2 PKO mice on a
HFD, which had the highest mean body weight. C3 was increased
in plasma of male and female LDLR2/2 PKO versus LDLR2/2
PWT mice fed a LFD or HFD (Table 1) consistent with impaired
AP activity in LDLR2/2 PKO, which we confirmed using the
standard rabbit red blood cell lysis assay (data not shown). Levels
of C3adesArg, which are generated by cleavage of plasma C3a
appeared to be lower in HFD than LFD fed male LDLR2/2 PWT
(0.5760.10 mg/dl vs 0.7660.05 mg/dl) but this did not reach
statistical significance (Table 1). Because of the elevated C3 levels
in LDLR2/2PKO, the ratio of ASP/C3 was consistently decreased
by 50% in the absence of properdin regardless of diet or gender
(Table 1). We also examined cell and platelet counts at six-weekly
intervals (Figure S1 and S2 in File S1). Male LDLR2/2 and
LDLR2/2 PKO and female LDLR2/2 and LDLR2/2 PKO mice
had similar numbers of lymphocytes, monocytes and neutrophils
at the onset of the study (LFD and HFD). The mean weekly blood
pressures did not show differences between the groups after 12
weeks’ diet (Figure S3 in File S1). Fed a LFD, female LDLR2/2
mice at comparable cholesterol levels to male LDLR2/2 mice
developed greater aortic lesions, as previously described [11].
We assessed atherosclerosis in aortae using an en face lipid
staining method (to evaluate overall burden and distribution of
disease) and at the aortic root (area of predilection for
atherosclerosis in the mouse models). Lesions occurred throughout
the proximal and distal aorta and the largest lesion burden in our
study was in female LDLR2/2 PWT and female LDLR2/2 PKO
mice on HFDs. This appeared to be two-fold more than their male
counterparts on HFD (Fig. 1A). The en face oil red O staining for
lesion burden within whole aortae showed that properdin was
protective only in male mice fed a LFD (Figure 1A). This
protective effect was overwhelmed by feeding of a HFD
(Figure 1A). Atherosclerotic plaque formation at the aortic root
was also significantly larger in male LDLR2/2PKO mice fed a
LFD compared with wild type littermate controls (Figure 1B).
Plaques were distributed along the thoracic aorta (Figure 1C) and
plaque formation was within subendothelial layers (Figure 1 D).
Figure 2. Properdin deficiency promotes increased macro-
phages in atherosclerotic lesions after feeding on a low fat
diet. Quantitative immunohistochemistry of (A) % smooth muscle cells
in aortic root plaques of male and female LDLR2/2PKO versus LDLR2/
2PWT mice. Random areas in 15–20 plaques from n=4–5 mice/group
were analysed under high magnification using NIS elements software.
Data presented are mean and IQR (B) Macrophage (MAC 387) index
(percentage of the total cells/high power field within plaques) from the
relevant groups, n = 5 mice/group were examined, mean and IQR, p,
0.05, intergenotype comparisons were by two way ANOVA with a Mann
Whitney U post test. (C) M2 (CD206) macrophage index, n = 5 mice/
group examined, mean +/2 SEM, p,0.05 (2 way ANOVA and Mann
Whitney U test).
doi:10.1371/journal.pone.0092404.g002
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Properdin Dampens Development of Atherosclerosis in
Male LFD fed LDLR2/2
Subsequent analyses focussed on LDLR2/2PKO and LDLR2/
2PWT mice fed LFD since the largest effects of the properdin
genotype were seen in mild rather than advanced atherosclerosis.
Immunostaining of aortic sinus plaques from male and female
LDLR2/2PKO and LDLR2/2PWT mice for smooth muscle cell
actin (smooth muscle cells), high resolution imaging and subse-
quent analysis showed that there were no significant differences in
the % VSMC/plaque area between these groups (Figure 2A)
although a trend for lower SMA in LDLR2/2PKO compared with
LDLR2/2PWT mice was observed. In contrast, there was a
significant increase in the % macrophages/plaque area between
male LDLR2/2PKO and LDLR2/2PWT (Figure 2B). Further,
CD206 (mannose receptor) staining revealed a significant increase
in M2 macrophages within LDLR2/2PKO plaques in male mice
fed a LFD compared with LDLR2/2PWT littermates (Figure 2C).
This difference was not seen in female mice fed a LFD.
The greater plaque area in LDLR2/2 PKO mice appears not to
be connected with differences in plasma cholesterol or triglycerides
since these were similar amongst groups (Table 1). However, we
noted that at the endpoint of the experiment, male LDLR2/2
PKO mice had significantly elevated platelets and depressed
neutrophils compared to LDLR2/2 PWT mice (Figure S2C and
Figure S1C in File S1).
Because macrophage numbers, especially M2 macrophages
were increased in lesions (Figures 2B and 2C), we also examined
macrophage function. The ability of bone marrow-derived
macrophages from male LDLR2/2PKO and LDLR2/2PWT to
store lipid droplets was examined in vitro. LDLR2/2 PKO
macrophages had nearly twice the storage capacity of LDLR2/
2PWT macrophages (Table 2). To investigate systemic correlates of
greater accumulation of macrophages in LDLR2/2PKO athero-
sclerotic lesions (LFD group), the expression of a number of
signature genes for M2 macrophage polarisation was examined.
MCP-1 and sPLA2-V mRNA expression were increased in male
LDLR2/2PKO fed a LFD compared with LDLR2/2PWT. C3
mRNA expression, consistent with the systematic analysis
conducted by others for M1 and M2 macrophages in parallel
[12], was expectedly decreased in macrophages from LDLR2/
2PKO (Fig. 3A). Further, arginase 1, a marker of alternatively
activated (M2) macrophages in experimental models of athero-
sclerosis, was increased 50 fold at the mRNA level in splenocytes of
LDLR2/2PKO compared with LDLR2/2PWT (Fig. 3B). Taken
together, properdin deficiency on LDLR2/2 background is
associated with increased expression of M2-type macrophage
Figure 3. Properdin deficiency promotes macrophage mRNA synthesis typical of M2 macrophages under conditions of
atherosclerosis. (A) Spleens from male LDLR2/2PKO and LDLR2/2PWT fed a LFD were analysed for various mRNA species including C3 (500 bp),
sPLA2-V (329 bp) and MCP-1 (490 bp) by RTPCR. b-actin (540 bp) was control. (B) Arginase 1 mRNA expression was enhanced 50 fold in splenic
macrophages from male LDLR2/2PKO compared to LDLR2/2PWT fed a LFD. Representative images and analyses of matched pairs are shown.
doi:10.1371/journal.pone.0092404.g003
Table 2. Enhanced lipid storage in properdin-deficient macrophages isolated from pro-atherosclerotic mice.
LDLR2/2PWT 648 cells counted LDLR2/2PKO 610 cells counted
Oil Red O pos cytoplasm 18.2% 32.6%
Oil Red O neg cytoplasm 81.8% 67.4%
Bone marrow derived macrophages (BMDM) from male LDLR2/2PKO mice have the capacity to store more LDL as lipid droplets within cells than LDLR2/2PWT. 610–648
cells counted.
doi:10.1371/journal.pone.0092404.t002
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inflammatory response in aortic lesions and in the systemic
compartment.
Discussion
Previous in vivo studies have concluded that complement
activation plays a role in atherosclerotic lesions. However, the
overall role of complement is complex and the positive regulator of
C3 activation, properdin, has not been studied in experimental
atherosclerosis. Our comprehensive study indicates a protective
effect of properdin in male mice but only under conditions of
‘mild’ atherosclerosis. We show that as a result of properdin
deletion on a hyperlipidemic background, circulating complement
C3 accumulates, alternatively activated (M2) macrophage infiltra-
tion in aortic lesions is enhanced and lesion size is increased. In
more advanced disease with significant hypercholesterolemia, this
protective effect is overwhelmed by other systems and signalling
pathways.
C3 behaves as an acute phase reactant similar to CRP and is
increased in atherosclerotic lesions [13]. C3 deficient mice have
significantly larger atherosclerotic lesions than LDLR2/2 C3
sufficient controls [14,15] but not Factor B deficient mice on
ApoE2/2 LDLR2/2 background [14]. This concurs with Malik
et al. [7], who studied Bf2/2/LDLR2/2 and found no difference
in serum C3 levels and no difference in atherosclerotic lesion
development compared to LFD fed Factor B sufficient controls.
However, on HFD, Bf2/2/LDLR2/2 developed elevated C3
levels but fared better than WT, possibly due to a reduction in
cholesterol.
There are methodological differences between the study by
Persson [14] and our study. For example, Persson et al. did not use
fat feeding but rather double transgenics LDLR2/2 ApoE2/2
spontaneously developing atherosclerosis on a mixed C57BL/6/
129Ola background. The methodology used by Persson also
contrasts to the study by Malik [7] who studied female mice on
LDLR2/2 background (strain C57BL/6) and fed LF and LF with
LPS and LPS plus HF diets. Our comprehensive study reported
herein used the LDLR2/2 background, male and female mice and
low and high fat diets. We used both genders since gender specific
differences in complement studies in mice are well recognised [16]
and complement proteins appear to be variably influenced by
gender and different decay rates of C3b/iC3b have been reported
between female and male mice [17]. Our study is unique in that
both genders of mice on two different diets have been studied.
Complement proteins might reasonably be expected to alter
lipid levels in pathological situations [6]. In our study, there was no
impact of properdin upon these. Interestingly, LDLR2/2 PKO
male mice had reduced NEFA levels compared to their
corresponding wild type mice on HFD, but the reduction did
not impact favourably on the size of aortic lesions. Elevated NEFA
have previously been shown to modulate atherosclerosis in a
mouse model although the exact mechanisms involved are unclear
[18]. Although we detected an altered function of LDLR2/2 PKO
BMDMs to store more lipid in an in vitro assay, we saw no
increases in the size of the lipid cores in lesions in our model.
Lesional macrophages and in particular CD206+ macrophages,
were increased in male LDLR2/2 PKO mice. While the basal
mRNA expression for C3 was lower in macrophages from
LDLR2/2 PKO mice than in those from LDLR2/2 PWT mice,
additional sources of C3 production (adipocytes, hepatocytes) in
combination with reduced C3 conversion in the absence of
properdin are likely to account for the elevated C3 protein levels
we measured in LDLR2/2PKO versus LDLR2/2 PWT mice.
Contrasting with the increase in C3 in LDLR2/2PKO versus
LDLR2/2 PWT mice, there was no difference in its cleavage
product C3adesArg, also known as ASP. Since there has been
increasing interest in C3 cleavage products such as C3adesarg
(ASP), which has been linked to obesity, we measured weight gain
in our study. Although female mice had more atherosclerosis, male
mice had a consistently higher body weight than females in this
study but deletion of properdin had no overall significant effect
upon this or the weight of fat pads in either gender (data not
shown). At the mid-point of the experiment, atherosclerotic male
LDLR2/2 PKO mice showed a trend towards less weight gain.
This tentatively suggests that properdin might have transient
effects on metabolism but that any effects were subtle on this
atherosclerotic background.
ASP is produced from C3 by adipsin and Factor B. Properdin
stabilizes the C3 convertase [19] so in the presence of properdin
there should be more ASP and less in its absence. Our data suggest
that in all diets and genders of mice, in the absence of properdin,
there is a decrease of up to 50% in the ratio of ASP/C3, consistent
with less production of ASP. Properdin was without direct effect
on ASP possibly because of variance in the fat composition in the
diet compared to other studies [20] and/or the alterations in
mechanisms of clearance of lipoproteins due to the absence of
LDLR. ASP is considered to be critical for triglyceride synthesis
and the maintenance of metabolic homeostasis [21], [22], [23]
although the importance of C3adesArg in systemic lipid metabolism
remains controversial and has been contradicted in previous
studies [15].
Hematological parameters were not changed throughout the
course of this study. While circulating factor D (of AP) inhibits
thrombin-induced platelet aggregation in vitro [24] there was no
effect of properdin deficiency on platelet number or activation at
any time point.
In terms of atherosclerotic plaque burden, properdin was
protective in male mice but only when fed a LFD. This concurs
with the study by Persson [14] who also found that positive effects
of C3 deletion were overwhelmed at later time points, 26 weeks in
that specific study. The authors linked the early phenotype to the
possible presence of neutrophils in lesions and since properdin is
produced by neutrophils [25] this could also play a role in our
study.
This early effect of properdin on lesions points to a potential
role in ‘mild’ rather than ‘moderate’ or ‘complex’ lesion formation.
In our study, there was no increase in VSMC whose excessive
proliferation as part of the stereotypic atherosclerotic process
causes thickened vessel walls and accumulation in plaques [26].
Only the % of macrophages in lesions and their phenotype
appeared altered by properdin deletion, with enhanced lipid
storage function and increased expression of CD206, MCP-1 and
arginase, supporting a likely M2 phenotype [27]. M2 macrophages
account for approximately 20% of the total macrophages in lesions
from LDLR2/2 mice fed a Western diet for 30 weeks [28] but
implications of this are not yet widely understood. It is known that
M2 macrophages are involved in tissue remodelling, repair and
the resolution of inflammation [29] and that macrophage
switching in lesions is known to be an early phenomenon in the
life cycle of plaque development in mouse models [30]. We suggest
that the balance of M1/M2 vs other M types and their individual
functions and interactions with other cell types e.g. neutrophils,
ultimately could determine overall lesion size and dynamics.
Interestingly, the development of the M2 macrophage pheno-
type is under the control of estrogen and progesterone [31], which
could explain the greater abundance of lesional CD206+ cells
observed for female LDLR2/2 in our study. The percentage of
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M2 macrophages in aortic root plaques was, however, not
increased further in the absence of properdin (fig. 2C). In keeping
with suggestions from Bacci and Fujisaka et al. [32,33] that M2
macrophages are over recruited under conditions of a high fat diet
especially when metabolic disturbance e.g. insulin resistance and
weight gain occurs, we find the greatest Oil red O lesion areas,
indicative of foam cells, in HFD fed female and male mice
(Fig. 1A).
In conclusion, this definitive study indicates that the positive
regulator of the alternative complement pathway has anti-
atherogenic effects in an unstressed (mild lesion) situation. This
effect appears restricted to male mice only and is overwhelmed by
feeding a HFD. We postulate that normal levels of C3 and the
presence of properdin appear to be protective in experimental
atherosclerosis. Properdin has a unique role in the complement
system and further studies directed at more metabolic aspects of
atherosclerosis may be valuable.
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File S1 Figure S1. Cell composition: Lymphocytes
(LYM, A), monocytes (MXD, B) and neutrophils (NEUT,
C) in whole blood of diet-induced atherosclerotic
LDLR2/2 PWT and LDLR2/2 PKO mice on LFD and
HFD. Data from 0, 6 and 12 weeks on diet and each set of 3 bars
represents these times. Bars represent Mean 6 SEM, numbers
below bars are the number of mice. Statistical analysis was
performed with two-way ANOVA. *P,0.05. Figure S2.
Haematological parameters: white blood cells (WBC,
A), red blood cells (RBC, B) and platelets (C) in whole
blood of diet-induced atherosclerotic LDLR2/2 PWT and
LDLR2/2 PKO mice on LFD and HFDs. Data have been
collected at 0, 6 and 12 weeks on diet and each set of 3 bars
represents these times. There are some decreases in platelet
number between PWT and PKO on LFD but these resolve over
time up to 12 weeks. Bars represent Mean 6 SEM, numbers
below bars represent number of mice. Statistical analysis was
performed with two-way ANOVA. *P,0.05, **P,0.01, ***P,
0.005. Figure S3. Blood pressure measured using tail cuff
plethysmography. A) male mice, B) female mice, fed a low and
high fat diet with or without Properdin deletion. Data represent
Mean 6 SEM. There were no statistical differences using two-way
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